GlassScriptPhysician profile
Sampreet Singh Dhaliwal
NPI 1881339539
$902.70
in general payments reported to CMS, 2019-2025
6 companies · $236 in 2025
The $236 reported for 2025 was more than what 83% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $115 · 2024: $551 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $336.17 | 2023-2024 | Exparel |
| Avanos Medical | $272.63 | 2024-2025 | On-Q Pump and Accessories, On-Q* Pump and Accessories |
| Eagle Pharmaceuticals, INC. | $120.18 | 2024 | |
| Heron Therapeutics, INC. | $118.75 | 2024 | Zynrelef, Aponvie |
| Becton, Dickinson and Company | $39.48 | 2025 | Hemosphere |
| Aero US INC | $15.49 | 2025 | Aerogen Solo Nebulizer System, Aerogen Usb Controller System, Aerogen Solo; Aerogen Ultra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sampreet Dhaliwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.